Eureka Acquisition Corp announced the pricing of its $50 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EURKU”, Tuesday, July 2, 2024.
The new SPAC aims to combine with a target in Asia utilizing the team’s established deal-sourcing network among private equity and venture capital firms in the region.
Eureka’s sponsor team will be led by CEO and Chairman Fen Zhang and CFO Zhechen Wang. Its Board includes M. Anthony Wong, Lauren Simmons and Kevin McKenzie.
Total SPAC deal count for 2024 year-to-date is now 17. This offering is expected to close on Wednesday, July 3, 2024.
Maxim Group is acting as the sole book-running manager for the offering. Robinson+Cole LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. Marcum Asia CPAs LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...
Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...
At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...
Bold Eagle Acquisition Corp. announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “BEAGU”, Thursday, October 24, 2024. The new SPAC plans to search for a combination target valued at $3 billion or more that would benefit from the relationships and experience...
Oaktree Acquisition Corp. III Life Sciences announced the pricing of its $175 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “OACCU”, Thursday, October 24, 2024. The new SPAC plans to combine with a healthcare target or one in a healthcare-related industry in North America or Europe. The...